Chemical tools to explore nutrient-driven O-GlcNAc cycling

References

• Agard NJ, Bertozzi CR. (2009). Chemical approaches to perturb, profile, and perceive glycans. Acc Chem Res 42:788–97
   PubMed Web of Science ®Google Scholar
• Andrali SS, März P, Özcan S. (2005). Ataxin-10 interacts with O-GlcNAc transferase OGT in pancreatic β cells. Biochem Biophys Res Commun 337:149–53
   Google Scholar
• Beck M, Brickley K, Wilkinson HL, et al. (2002). Identification, molecular cloning, and characterization of a novel GABAA receptor-associated protein, GRIF-1. J Biol Chem 277:30079–90
   PubMed Web of Science ®Google Scholar
• Blatch GL, Lässle M. (1999). The tetratricopeptide repeat: a structural motif mediating protein-protein interactions. BioEssays 21:932–9
   PubMed Web of Science ®Google Scholar
• Blom N, Sicheritz-Pontén T, Gupta R, et al. (2004). Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 4:1633–49
   PubMed Web of Science ®Google Scholar
• Borodkin VS, Schimpl M, Gundogdu M, et al. (2013). Bisubstrate UDP-peptide conjugates as human O-GlcNAc transferase inhibitors. Biochem J 457:497–502
   Google Scholar
• Butkinaree C, Cheung WD, Park S, et al. (2008). Characterization of β-N-acetylglucosaminidase cleavage by caspase-3 during cpoptosis. J Biol Chem 283:23557–66
   Google Scholar
• Caldwell SA, Jackson SR, Shahriari KS, et al. (2010). Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene 29:2831–42
   PubMed Web of Science ®Google Scholar
• Cantarel BL, Coutinho PM, Rancurel C, et al. (2009). The carbohydrate-active enZymes database (CAZy): an expert resource for glycogenomics. Nucleic Acids Res 37:D233–8
   PubMed Web of Science ®Google Scholar
• Capotosti F, Guernier S, Lammers F, et al. (2011). O-GlcNAc Transferase catalyzes site-specific proteolysis of HCF-1. Cell 144:376–88
   PubMed Web of Science ®Google Scholar
• Carrillo LD, Froemming JA, Mahal LK. (2011). Targeted in vivo O-GlcNAc sensors reveal discrete compartment-specific dynamics during signal transduction. J Biol Chem 286:6650–8
   PubMed Web of Science ®Google Scholar
• Çetinbaş N, Macauley MS, Stubbs KA, et al. (2006). Identification of Asp174 and Asp175 as the key catalytic residues of human O-GlcNAcase by functional analysis of site-directed mutants. Biochemistry 45:3835–44
   PubMed Web of Science ®Google Scholar
• Champattanachai V, Marchase RB, Chatham JC. (2008). Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am J Physiol Cell Physiol 294:C1509–20
   PubMed Web of Science ®Google Scholar
• Chatham JC, Marchase RB. (2010). Protein O-GlcNAcylation: a critical regulator of the cellular response to stress. Curr Signal Transduct Ther 5:49–59
   Google Scholar
• Cheung WD, Hart GW. (2008). AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation. J Biol Chem 283:13009–20
   Google Scholar
• Cheung WD, Sakabe K, Housley MP, et al. (2008). O-Linked β-N-acetylglucosaminyltransferase substrate specificity is regulated by myosin phosphatase targeting and other interacting proteins. J Biol Chem 283:33935–41
   PubMed Web of Science ®Google Scholar
• Clarke AJ, Hurtado-Guerrero R, Pathak S, et al. (2008). Structural insights into mechanism and specificity of O-GlcNAc transferase. EMBO J 27:2780–8
   Google Scholar
• Comer FI, Hart GW. (2001). Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA Polymerase II. Biochemistry 40:7845–52
   PubMed Web of Science ®Google Scholar
• Conti E, Kuriyan J. (2000). Crystallographic analysis of the specific yet versatile recognition of distinct nuclear localization signals by karyopherin α. Structure 8:329–38
   PubMed Web of Science ®Google Scholar
• Conti E, Uy M, Leighton L, et al. (1998). Crystallographic analysis of the recognition of a nuclear localization signal by the nuclear import factor karyopherin α. Cell 94:193–204
   PubMed Web of Science ®Google Scholar
• D'Andrea LD, Regan L. (2003). TPR proteins: the versatile helix. Trends Biochem Sci 28:655–62
   PubMed Web of Science ®Google Scholar
• David LS, Tracey MG, Scott AY, David JV. (2012). Insights into O-linked N-acetylglucosamine (O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates. J Biol Chem 287:15395–408
   Google Scholar
• Dehennaut V, Lefebvre, T, Sellier C, et al. (2007). O-Linked N-acetylglucosaminyltransferase inhibition prevents G2/M Transition in Xenopus laevis oocytes. J Biol Chem 282:12527–36
   PubMed Web of Science ®Google Scholar
• Dion HW, Fusari SA, Jakubowski ZL, et al. (1956). 6-Diazo-5-oxo-L-norleucine, a new tumor-inhibitory substance. II. Isolation and characterization. J Am Chem Soc 78:3075–7
   Web of Science ®Google Scholar
• Dorfmueller HC, Borodkin VS, Blair DE, et al. (2011). Substrate and product analogues as human O-GlcNAc transferase inhibitors. Amino Acids 40:781–92
   PubMed Web of Science ®Google Scholar
• Du J, Meledeo MA, Wang Z, et al. (2009). Metabolic glycoengineering: sialic acid and beyond. Glycobiology 19:1382–401
   PubMed Web of Science ®Google Scholar
• Du XL, Edelstein D, Dimmeler S, et al. (2001). Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108:1341–8
   PubMed Web of Science ®Google Scholar
• Fletcher BS, Draqstedt C, Notterpek L, Nolan GP. (2002). Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles in cell cycle progression. Leukemia 16:1507–18
   PubMed Web of Science ®Google Scholar
• Gao Y, Miyazaki J-I, Hart GW. (2003). The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 β-cells. Arch Biochem Biophys 415:155–63
   PubMed Web of Science ®Google Scholar
• Gao Y, Wells L, Comer FI, et al. (2001). Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain. J Biol Chem 276:9838–45
   PubMed Web of Science ®Google Scholar
• Gloster TM, Vocadlo DJ. (2010) Mechanism, structure, and inhibition of O-GlcNAc processing enzymes. Curr Signal Transduct Ther 5:74–91
   Google Scholar
• Gloster TM, Zandberg WF, Heinonen JE, et al. (2011). Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cells. Nat Chem Biol 7:174–81
   PubMed Web of Science ®Google Scholar
• Gross BJ, Kraybill BC, Walker S. (2005). Discovery of O-GlcNAc transferase inhibitors. J Am Chem Soc 127:14588–9
   PubMed Web of Science ®Google Scholar
• Gross BJ, Swoboda JG, Walker S. (2008). A strategy to discover inhibitors of O-linked glycosylation. J Am Chem Soc 130:440–1
   PubMed Web of Science ®Google Scholar
• Hahne H, Sobotzki N, Nyberg T, et al. (2013). Proteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometry. J Proteome Res 12:927–36
   PubMed Web of Science ®Google Scholar
• Hajduch J, Nam G, Kim EJ, et al. (2008). A convenient synthesis of the C-1-phosphonate analogue of UDP-GlcNAc and its evaluation as an inhibitor of O-linked GlcNAc transferase (OGT). Carbohydr Res 343:189–95
   Google Scholar
• Haltiwanger RS, Blomberg MA, Hart GW. (1992). Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine: polypeptide β-N-acetylglucosaminyltransferase. J Biol Chem 267:9005–13
   PubMed Web of Science ®Google Scholar
• Haltiwanger RS, Holt GD, Hart GW. (1990). Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine:peptide β-N-acetylglucosaminyltransferase. J Biol Chem 265:2563–8
   PubMed Web of Science ®Google Scholar
• Hanover JA. (2001). Glycan-dependent signaling: O-linked N-acetylglucosamine. FASEB J 15:1865–76
   PubMed Web of Science ®Google Scholar
• Hanover JA, Forsythe ME, Hennessey PT, et al. (2005). A Caenorhabditis elegans model of insulin resistance: altered macronutrient storage and dauer formation in an OGT-1 knockout. Proc Natl Acad Sci USA 102:11266–71
   PubMedGoogle Scholar
• Hanover JA, Yu S, Lubas WB, et al. (2003). Mitochondrial and nucleocytoplasmic isoforms of O-linked GlcNAc transferase encoded by a single mammalian gene. Arch Biochem Biophys 409:287–97
   PubMed Web of Science ®Google Scholar
• Hart GW, Housley MP, Slawson C. (2007). Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446:1017–22
   PubMed Web of Science ®Google Scholar
• Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O. (2011). Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem 80:825–58
   PubMed Web of Science ®Google Scholar
• He Y, Macauley MS, Stubbs KA, et al. (2010). Visualizing the reaction coordinate of an O-GlcNAc hydrolase. J Am Chem Soc 132:1807–9
   Google Scholar
• Housley MP, Udeshi ND, Rodgers JT, et al. (2009). A PGC-1α-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose. J Biol Chem 284:5148–57
   PubMed Web of Science ®Google Scholar
• Huber AH, Weis WI. (2001). The structure of the β-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by β-catenin. Cell 105:391–402
   PubMed Web of Science ®Google Scholar
• Iyer SPN, Akimoto Y, Hart GW. (2003). Identification and cloning of a novel family of coiled-coil domain proteins that interact with O-GlcNAc transferase. J Biol Chem 278:5399–409
   PubMed Web of Science ®Google Scholar
• Iyer SPN, Hart GW. (2003). Roles of the tetratricopeptide repeat domain in O-GlcNAc transferase targeting and protein substrate specificity. J Biol Chem 278:24608–16
   PubMed Web of Science ®Google Scholar
• Izumi M, Yuasa H, Hashimoto H. (2009). Bisubstrate analogues as glycosyltransferase inhibitors. Curr Top Med Chem 9:87–105
   PubMed Web of Science ®Google Scholar
• Jancan I, Macnaughtan MA. (2012). Acid dissociation constants of uridine-5′-diphosphate compounds determined by 31phosphorus nuclear magnetic resonance spectroscopy and internal pH referencing. Anal Chim Acta 749:63–9
   Google Scholar
• Jia C, Liu T, Wang Z. (2013). O-GlcNAcPRED: a sensitive predictor to capture protein O-GlcNAcylation sites. Mol BioSyst 9:2909–13
   Google Scholar
• Jiang J, Lazarus MB, Pasquina L, et al. (2012). A neutral diphosphate mimic crosslinks the active site of human O-GlcNAc transferase. Nat Chem Biol 8:72–7
   Google Scholar
• Jinek M, Rehwinkel J, Lazarus BD, et al. (2004). The superhelical TPR-repeat domain of O-linked GlcNAc transferase exhibits structural similarities to importin α. Nat Struct Mol Biol 11:1001–7
   PubMed Web of Science ®Google Scholar
• Jones MB, Teng H, Rhee JK, et al. (2004). Characterization of the cellular uptake and metabolic conversion of acetylated N-acetylmannosamine (ManNAc) analogues to sialic acids. Biotechnol Bioeng 85:394–405
   Google Scholar
• Kang E-S, Han D, Park J, et al. (2008). O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic β cells. Exp Cell Res 314:2238–48
   Google Scholar
• Keppler OT, Horstkorte R, Pawlita M, et al. (2001). Biochemical engineering of the N-acyl side chain of sialic acid: biological implications. Glycobiology 11:11R–8R
   PubMed Web of Science ®Google Scholar
• Kim EJ. (2011). Chemical arsenal for the study of O-GlcNAc. Molecules 16:1987–2022
   Google Scholar
• Kim EJ, Hanover JA. (2013). Enzymatic characterization of recombinant enzymes of O-GlcNAc cycling. In: Brockhausen I, ed. Methods in molecular biology. Volume 1022: glycosyltransferase: methods and protocols. New York: Human Press, 129–45
   Google Scholar
• Kim EJ, Abramowitz LK, Bond MR, et al. (2014). Versatile O-GlcNAc transferase assay for high-throughput identification of enzyme variants, substrates, and inhibitors. Bioconjug Chem. DOI: 10.1021/bc5001774
   Google Scholar
• Kim EJ, Kang DO, Love DC, Hanover JA. (2006a). Enzymatic characterization of O-GlcNAcase isoforms using a fluorogenic GlcNAc substrate. Carbohydr Res 341:971–82
   PubMed Web of Science ®Google Scholar
• Kim EJ, Perreira M, Thomas CJ, Hanover JA. (2006b). An O-GlcNAcase-specific inhibitor and substrate engineered by the extension of the N-acetyl moiety. J Am Chem Soc 128:4234–5
   PubMed Web of Science ®Google Scholar
• Knight ZA, Shokat KM. (2007). Chemical genetics: where genetics and pharmacology meet. Cell 128:425–30
   PubMed Web of Science ®Google Scholar
• Koivula A, Ruohonen L, Wohlfahrt G, et al. (2002). The active site of cellobiohydrolase Cel6A from Trichoderma reesei: the roles of aspartic acids D221 and D175. J Am Chem Soc 124:10015–24
   Google Scholar
• Kolm-Litty V, Sauer U, Nerlich A, et al. (1998). High glucose-induced transforming growth factor β1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 101:160–9
   PubMed Web of Science ®Google Scholar
• Konrad RJ, Zhang F, Hale JE, et al. (2002). Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase. Biochem Biophys Res Commun 293:207–12
   PubMed Web of Science ®Google Scholar
• Kreppel LK, Blomberg MA, Hart GW. (1997). Dynamic glycosylation of nuclear and cytosolic proteins: cloning and charaterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J Biol Chem 272:9308–15
   PubMed Web of Science ®Google Scholar
• Kreppel LK, Hart GW. (1999). Regulation of a cytosolic and nuclear O-GlcNAc transferase: role of the tetratricopeptide repeats. J Biol Chem 274:32015–22
   PubMed Web of Science ®Google Scholar
• Laczy B, Hill BG, Wang K, et al. (2009). Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system. Am J Physiol Heart Circ Physiol 296:H13–28
   Google Scholar
• Lavogina D, Enkvist E, Uri A. (2010). Bisubstrate inhibitors of protein kinases: from principle to practical applications. Chem Med Chem 5:23–34
   Web of Science ®Google Scholar
• Lazarus BD, Love DC, Hanover JA. (2006). Recombinant O-GlcNAc transferase isoforms: identification of O-GlcNAcase, yes tyrosine kinase, and tau as isoform-specific substrates. Glycobiology 16:415–21
   Google Scholar
• Lazarus BD, Love DC, Hanover JA. (2009). O-GlcNAc cycling: implications for neurodegenerative disorders. Int J Biochem Cell Biol 41:2134–46
   Google Scholar
• Lazarus MB, Jiang J, Gloster TM, et al. (2012). Structural snapshots of the reaction coordinate for O-GlcNAc transferase. Nat Chem Biol 8:966–8
   Google Scholar
• Lazarus MB, Nam Y, Jiang J, et al. (2011). Structure of human O-GlcNAc transferase and its complex with a peptide substrate. Nature 469:564–7
   PubMed Web of Science ®Google Scholar
• Leavy TM, Bertozzi CR. (2007). A high-throughput assay for O-GlcNAc transferase detects primary sequence preferences in peptide substrates. Bioorg Med Chem Lett 17:3851–4
   PubMed Web of Science ®Google Scholar
• Lee TN, Alborn WE, Knierman MD, Konrad RJ. (2006). Alloxan is an inhibitor of O-GlcNAc-selective N-acetyl-β-D-glucosaminidase. Biochem Biophys Res Commun 350:1038–43
   Google Scholar
• Lenzen S, Munday R. (1991). Thiol-group reactivity, hydrophilicity and stability of alloxan, its reduction products and its N-methyl derivatives and a comparison with ninhydrin. Biochem Pharmacol 42:1385–91
   PubMed Web of Science ®Google Scholar
• Lenzen S, Panten U. (1988). Alloxan: history and mechanism of action. Diabetologia 31:337–42
   PubMed Web of Science ®Google Scholar
• Liu F, Iqbal K, Grundke-Iqbal I, et al. (2004). O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc Natl Acad Sci USA 101:10804–9
   PubMed Web of Science ®Google Scholar
• Liu J, Marchase RB, Chatham JC. (2007). Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels. J Mol Cell Cardiol 42:177–85
   PubMed Web of Science ®Google Scholar
• Liu J, Pang Y, Chang T, et al. (2006). Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia. J Mol Cell Cardiol 40:303–12
   Google Scholar
• Liu J, Yu Y, Fan YZ, et al. (2005). Cardiovascular effects of endomorphins in alloxan-induced diabetic rats. Peptides 26:607–14
   PubMed Web of Science ®Google Scholar
• Liu X, Li L, Wang Y, et al. (2014). A peptide panel investigation reveals the acceptor specifity of O-GlcNAc transferase. FASEB J [Online] Available from: http://www.fasebj.org/content/early/2014/04/23/fj.13-246850.long [last accessed 23 April 2014]
   Google Scholar
• Love DC, Hanover JA. (2005). The hexosamine signaling pathway: deciphering the “O-GlcNAc Code.” Sci STKE 2005, re13
   Google Scholar
• Love DC, Kochran J, Cathey RL, et al. (2003). Mitochondrial and nucleocytoplasmic targeting of O-linked GlcNAc transferase. J Cell Sci 116:647–54
   PubMed Web of Science ®Google Scholar
• Lubas WA, Frank DW, Krause M, Hanover JA. (1997). O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J Biol Chem 272:9316–24
   PubMed Web of Science ®Google Scholar
• Lubas WA, Hanover JA. (2000). Functional expression of O-linked GlcNAc transferase: domain structure and substrate specificity. J Biol Chem 275:10983–8
   PubMed Web of Science ®Google Scholar
• Müller R, Jenny A, Stanley P. (2013). The EGF repeat-specific O-GlcNAc-transferase Eogt interacts with notch signaling and pyrimidine metabolism pathways in Drosophila. PLoS ONE 8:e62835
   PubMed Web of Science ®Google Scholar
• Macauley MS, Vocadlo DJ. (2010). Increasing O-GlcNAc levels: an overview of small-molecule inhibitors of O-GlcNAcase. Biochim Biophys Acta 1800:107–21
   Google Scholar
• Macauley MS, Whitworth GE, Debowski AW, et al. (2005). O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors. J Biol Chem 280:25313–22
   PubMed Web of Science ®Google Scholar
• Majumdar G, Harmon A, Candelaria R, et al. (2003). O-glycosylation of Sp1 and transcriptional regulation of the calmodulin gene by insulin and glucagon. Am J Physiol Endocrinol Metab 285:E584–91
   Google Scholar
• Marshall S, Bacote V, Traxinger RR. (1991). Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706–12
   PubMed Web of Science ®Google Scholar
• Martinez-Fleites C, Macauley MS, He Y, et al. (2008). Structure of an O-GlcNAc transferase homolog provides insight into intracellular glycosylation. Nat Struct Mol Biol 15:764–5
   Google Scholar
• Mayer TU. (2003). Chemical genetics: tailoring tools for cell biology. Trends Cell Biol 13:270–7
   Google Scholar
• McClain DA, Lubas WA, Cooksey RC, et al. (2002). Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc Natl Acad Sci USA 99:10695–9
   PubMed Web of Science ®Google Scholar
• Ngoh GA, Facundo HT, Zafir A, Jones SP. (2010). O-GlcNAc signaling in the cardiovascular system. Circ Res 107:171–85
   PubMed Web of Science ®Google Scholar
• Ngoh GA, Watson LJ, Facundo HT, et al. (2008). Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition. J Mol Cell Cardiol 45:313–25
   PubMed Web of Science ®Google Scholar
• Noach N, Segev Y, Levi I, et al. (2007). Modification of topoisomerase I activity by glucose and by O-Glcnacylation of the enzyme protein. Glycobiology 17:1357–64
   Google Scholar
• Nolte D, Müller U. (2002). Human O-GlcNAc transferase (OGT): genomic structure, analysis of splice variants, fine mapping in Xq13.1. Mamm Genome 13:62–4
   PubMed Web of Science ®Google Scholar
• O'Donnell N, Zachara NE, Hart GW, Marth JD. (2004). Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol Cell Biol 24:1680–90
   PubMedGoogle Scholar
• Offen W, Martinez-Fleites C, Yang M, et al. (2006). Structure of a flavonoid glucosyltransferase reveals the basis for plant natural product modification. EMBO J 25:1396–405
   PubMed Web of Science ®Google Scholar
• Olszewski NE, West CM, Sassi SO, Hartweck LM. (2010). O-GlcNAc protein modification in plants: evolution and function. Biochim Biophys Acta 1800:49–56
   Google Scholar
• Ostrowski A, van Aalten DMF. (2013). Chemical tools to probe cellular O-GlcNAc signalling. Biochem J 456:1–12
   Google Scholar
• Palcic MM, Heerze LD, Srivastava OP, Hindsgaul O. (1989). A bisubstrate analog inhibitor for alpha (1- - - -2)-fucosyltransferase. J Biol Chem 264:17174–81
   PubMed Web of Science ®Google Scholar
• Rao FV, Schüttelkopf AW, Dorfmueller HC, et al. (2013). Structure of a bacterial putative acetyltransferase defines the fold of the human O-GlcNAcase C-terminal domain. Open Biol 3:130021
   Google Scholar
• Rex-Mathes M, Werner S, Strutas D, et al. (2001). O-GlcNAc expression in developing and ageing mouse brain. Biochimie 83:583–90
   PubMed Web of Science ®Google Scholar
• Ryu IH, Do SI. (2011). Denitrosylation of S-nitrosylated OGT is triggered in LPS-stimulated innate immune response. Biochem Biophys Res Commun 408:52–7
   Google Scholar
• Sakaidani Y, Ichiyanagi N, Saito C, et al. (2012). O-linked-N-acetylglucosamine modification of mammalian Notch receptors by an atypical O-GlcNAc transferase Eogt1. Biochem Biophys Res Commun 419:14–19
   PubMedGoogle Scholar
• Schimpl M, Zheng X, Borodkin VS, et al. (2012). O-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysis. Nat Chem Biol 8:969–74
   Google Scholar
• Shafi R, Iyer SPN, Ellies LG, et al. (2000). The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci USA 97:5735–9
   PubMed Web of Science ®Google Scholar
• Shaheen R, Aglan M, Keppler-Noreuil K, et al. (2013). Mutations in EOGT confirm the genetic heterogeneity of autosomal-recessive Adams-Oliver Syndrome. Am J Hum Genet 92:598–604
   PubMed Web of Science ®Google Scholar
• Sinclair DAR, Syrzycka M, Macauley MS, et al. (2009). Drosophila O-GlcNAc transferase (OGT) is encoded by the Polycomb group (PcG) gene, super sex combs (sxc). Proc Natl Acad Sci USA 106:13427–32
   PubMedGoogle Scholar
• Slawson C, Zachara NE, Vosseller K, et al. (2005). Perturbations in O-linked β-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. J Biol Chem 280:32944–56
   PubMed Web of Science ®Google Scholar
• Song M, Kim HS, Park JM, et al. (2008). O-GlcNAc transferase is activated by CaMKIV-dependent phosphorylation under potassium chloride-induced depolarization in NG-108-15 cells. Cell Signal 20:94–104
   Google Scholar
• Staiano N, Everson RB, Cooney DA, et al. (1980). Mutagenicity of d- and l-azaserine, 6-diazo-5-oxo-l-norleucine and N-(N-methyl-N-nitroso-carbamyl)-l-ornithine in the Salmonella test system. Mutat Res 79:387–90
   PubMed Web of Science ®Google Scholar
• Thornton TM, Swain SM, Olszewski NE. (1999). Gibberellin signal transduction presents ellipsisthe SPY who O-GlcNAc'd me. Trends Plant Sci 4:424–8
   Google Scholar
• Toleman C, Paterson AJ, Whisenhunt TR, Kudlow JE. (2004). Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities. J Biol Chem 279:53665–73
   PubMed Web of Science ®Google Scholar
• Tsuruta O, Shinohara G, Yuasa H, Hashimoto H. (1997). UDP-N-acetyl-5-thio-galactosamine is a substrate of lactose synthase. Bioorg Med Chem Lett 7:2523–6
   Web of Science ®Google Scholar
• Tsuruta O, Yuasa H, Hashimoto H, et al. (2003). Synthesis of GDP-5-thiosugars and their use as glycosyl donor substrates for glycosyltransferases. J Org Chem 68:6400–6
   PubMed Web of Science ®Google Scholar
• Tvaroška I, Kozmon S, Wimmerová M, Koča J. (2012). Substrate-assisted catalytic mechanism of O-GlcNAc transferase discovered by quantum mechanics/molecular mechanics investigation. J Am Chem Soc 134:15563–71
   Google Scholar
• Vocadlo DJ, Hang HC, Kim EJ, et al. (2003). A chemical approach for identifying O-GlcNAc-modified proteins in cells. Proc Natl Acad Sci USA 100:9116–21
   PubMed Web of Science ®Google Scholar
• Vosseller K, Wells L, Lane MD, Hart GW. (2002). Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 99:5313–18
   PubMed Web of Science ®Google Scholar
• Wang J, Torii M, Liu H, et al. (2011) dbOGAP-an integrated bioinformatics resource for protein O-GlcNAcylation. BMC Bioinforma 12:91
   Google Scholar
• Wells L, Kreppel LK, Comer FI, et al. (2004). O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits. J Biol Chem 279:38466–70
   PubMed Web of Science ®Google Scholar
• Wells L, Vosseller K, Hart GW. (2001). Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science 291:2376–8
   PubMed Web of Science ®Google Scholar
• Whelan SA, Lane MD, Hart GW. (2008). Regulation of the O-Linked β-N-acetylglucosamine transferase by insulin signaling. J Biol Chem 283:21411–17
   Google Scholar
• Whisenhunt TR, Yang X, Bowe DB, et al. (2006). Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development. Glycobiology 16:551–63
   PubMedGoogle Scholar
• Withers SG, Davies GJ. (2012). The case of the missing base. Nat Chem Biol 8:952–3
   Google Scholar
• Wrabl JO, Grishin NV. (2001). Homology between O-linked GlcNAc transferases and proteins of the glycogen phosphorylase superfamily. J Mol Biol 314:365–74
   PubMed Web of Science ®Google Scholar
• Wu F, Lukinius A, Bergström M, et al. (1999). A mechanism behind the antitumour effect of 6-diazo-5-oxo-l-norleucine (DON): disruption of mitochondria. Eur J Cancer 35:1155–61
   Google Scholar
• Xing D, Feng W, Nöt LG, et al. (2008). Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury. Am J Physiol Heart Circ Physiol 295:H335–42
   Google Scholar
• Yang X, Ongusaha PP, Miles PD, et al. (2008). Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature 451:964–9
   PubMed Web of Science ®Google Scholar
• Yang X, Zhang F, Kudlow JE. (2002). Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression. Cell 110:69–80
   PubMed Web of Science ®Google Scholar
• Yuzwa SA, Macauley MS, Heinonen JE, et al. (2008). A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat Chem Biol 4:483–90
   PubMed Web of Science ®Google Scholar
• Zachara NE, O'Donnell N, Cheung WD, et al. (2004). Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress: a survival response of mamalian cells. J Biol Chem 279:30133–42
   PubMed Web of Science ®Google Scholar
• Zhang F, Hu Y, Huang P, et al. (2007). Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6. J Biol Chem 282:22460–71
   PubMedGoogle Scholar
• Zhang F, Su K, Yang X, et al. (2003). O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115:715–25
   PubMed Web of Science ®Google Scholar
• Zhang H, Gao G, Brunk UT. (1992). Extracellular reduction of alloxan results in oxygen radical-mediated attack on plasma and lysosomal membranes. APMIS 100:317–25
   PubMedGoogle Scholar